InvestSMART

Archer Materials Limited (ASX:AXE)

ALERT: Price-sensitive ASX Announcement for AXE
Current share price for AXE : $0.225 -0.13 (-36.62%)+
Announcement
Release
25 Feb 2026 9:45AM
Price at Release
$0.355
Full Release
download
Summary
Archer Materials Limited, trading as ASX: AXE, released its Appendix 4D and half-year financial report for the period ending 31 December 2025. The company reported a net loss of AUD 2,993,137, a significant improvement from the previous year's loss. This loss included a share-based payments expense and substantial expenditures on research activities related to quantum and biochip technologies. Key achievements during the half-year include advancements in quantum technology, particularly in quantum readout and control of carbon qubit materials, and progress in biochip technology for medical diagnostics. Archer maintained a strong cash position of AUD 10.3 million to support its research and commercialization efforts, with no dividends declared for the period. Strategic partnerships and technology development, alongside the protection of intellectual property, were highlighted as critical components of the company's ongoing strategy.
Key Points
  • Net loss of AUD 2,993,137 for the half-year ended 31 December 2025.
  • Significant progress in quantum technology and biochip development.
  • Strong cash position of AUD 10.3 million as of 31 December 2025.
  • No dividends declared for the reporting period.
  • Key partnerships formed to advance technological and commercial goals.
  • Important advancements in quantum readout for carbon qubit materials.
  • Continued development of dual-platform biochip technology.
  • Strategic focus on integrating advances into functional prototypes.
  • Maintained efforts in protecting intellectual property assets.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.